首页 | 本学科首页   官方微博 | 高级检索  
     

沙利度胺治疗克罗恩病的研究进展
引用本文:徐萍萍,肖英莲,陈瑜君,陈白莉,何瑶,陈旻湖,胡品津. 沙利度胺治疗克罗恩病的研究进展[J]. 胃肠病学, 2012, 17(9): 570-572
作者姓名:徐萍萍  肖英莲  陈瑜君  陈白莉  何瑶  陈旻湖  胡品津
作者单位:中山大学附属第一医院消化科,510080
摘    要:克罗恩病(CD)是一种慢性非特异性肠道炎症性疾病,其发病机制尚未完全明确。近年来随着对肿瘤坏死因子(TNF)-α在CD发病机制中的认识,针对TNF—α的靶向治疗成为关注热点。沙利度胺因具有抑制TNF-α的特性,在CD尤其是难治性CD的治疗中起一定作用。本文就沙利度胺治疗CD的研究进展作一综述。

关 键 词:Crohn病  沙利度胺  英夫利昔  治疗

Progress in Study on Thalidomide for Treatment of Crohn's Disease
XU Pingping , XIAO Yinglian , CHEN Yujun , CHEN Baili , HE Yao , CHEN Minhu , HU Pinjin. Progress in Study on Thalidomide for Treatment of Crohn's Disease[J]. Chinese Journal of Gastroenterology, 2012, 17(9): 570-572
Authors:XU Pingping    XIAO Yinglian    CHEN Yujun    CHEN Baili    HE Yao    CHEN Minhu    HU Pinjin
Affiliation:.Department of Gastroenterology,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou(510080)
Abstract:Crohn's disease (CD) is a chronic non-specific intestinal inflammatory disease and its pathogenesis has not yet been fully clarified. In recent years, with the understanding of involvement of tumor necrosis factor (TNF)-α in the pathogenesis of CD, much attention has been paid on the TNF-α targeted therapy. Thalidomide has anti-TNF-α effect and has been used in the treatment of CD, especially refractory CD. This article reviewed the progress in study on thalidomide for the treatment of CD.
Keywords:Crohn Disease  Thalidomide  Infliximab  Therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号